The use of barrier contraception during sexual intercourse is advised to lower the risk of human papilloma virus (HPV) transmission (Dillner et al., 1996; Kjaer et al., 2001; Hernandez et al., 2008; Burchell et al., 2010; Widdice et al., 2013). | GPP |
All women starting medically assisted reproduction (MAR) should undergo testing to detect HPV-related cervical lesions. | GPP |